FR2702494B1 - Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer. - Google Patents

Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.

Info

Publication number
FR2702494B1
FR2702494B1 FR9302820A FR9302820A FR2702494B1 FR 2702494 B1 FR2702494 B1 FR 2702494B1 FR 9302820 A FR9302820 A FR 9302820A FR 9302820 A FR9302820 A FR 9302820A FR 2702494 B1 FR2702494 B1 FR 2702494B1
Authority
FR
France
Prior art keywords
hcg
cancer
immunotherapy
fragments
diagnostic kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9302820A
Other languages
English (en)
Other versions
FR2702494A1 (fr
Inventor
Rouas-Freiss Nathalie
Bidart Jean-Michel
Bellet Dominique
Troalen Frederic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9302820A priority Critical patent/FR2702494B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to PCT/FR1994/000265 priority patent/WO1994020859A1/fr
Priority to AU62112/94A priority patent/AU6211294A/en
Priority to NZ262435A priority patent/NZ262435A/en
Priority to JP6519675A priority patent/JPH08507604A/ja
Priority to EP94909172A priority patent/EP0688432A1/fr
Priority to CA002157868A priority patent/CA2157868A1/fr
Publication of FR2702494A1 publication Critical patent/FR2702494A1/fr
Application granted granted Critical
Publication of FR2702494B1 publication Critical patent/FR2702494B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9302820A 1993-03-11 1993-03-11 Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer. Expired - Fee Related FR2702494B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9302820A FR2702494B1 (fr) 1993-03-11 1993-03-11 Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
AU62112/94A AU6211294A (en) 1993-03-11 1994-03-10 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor
NZ262435A NZ262435A (en) 1993-03-11 1994-03-10 Kit for diagnosing an hcg fragment secreting cancer and immunotherapeutical means therefor
JP6519675A JPH08507604A (ja) 1993-03-11 1994-03-10 ｈＣＧまたはｈＣＧのフラグメントを分泌する癌に対する診断用キットおよびかような癌の免疫療法用手段
PCT/FR1994/000265 WO1994020859A1 (fr) 1993-03-11 1994-03-10 TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
EP94909172A EP0688432A1 (fr) 1993-03-11 1994-03-10 TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
CA002157868A CA2157868A1 (fr) 1993-03-11 1994-03-10 Trousse de diagnostic d'un cancer secretant l'hcg ou des fragments d'hcg et moyens destines a l'immunotherapie d'un tel cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302820A FR2702494B1 (fr) 1993-03-11 1993-03-11 Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.

Publications (2)

Publication Number Publication Date
FR2702494A1 FR2702494A1 (fr) 1994-09-16
FR2702494B1 true FR2702494B1 (fr) 1995-06-09

Family

ID=9444872

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9302820A Expired - Fee Related FR2702494B1 (fr) 1993-03-11 1993-03-11 Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.

Country Status (1)

Country Link
FR (1) FR2702494B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530521B (en) * 2014-09-24 2020-06-10 Map Ip Holding Ltd Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4876192A (en) * 1985-09-23 1989-10-24 Seven W. Enterprises, Inc. Detection of antibodies against a chorionic gonadotropin-like substance
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
GB8821507D0 (en) * 1988-09-14 1988-10-12 Cancer Res Campaign Tech Improvements relating to peptides
EP0553301A1 (fr) * 1990-10-17 1993-08-04 Yale University Procedes de detection et de suivi de l'evolution d'un cancer, de la grossesse ou d'une maladie trophoblastique

Also Published As

Publication number Publication date
FR2702494A1 (fr) 1994-09-16

Similar Documents

Publication Publication Date Title
EP0831880A4 (fr) Anticorps et fragments d'anticorps inhibant la croissance des tumeurs
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
IL136252A0 (en) Pharmaceutical and diagnostic compositions containing ab or fragments thereof
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
FI954269A0 (fi) Raiheinäsiitepölyallergeenin T-soluepitoopit
HK1048942A1 (zh) 引發抗n-羥乙酰化神經節苷脂免疫反應的疫苗組合物及其應用
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
AU4953693A (en) Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
FR2702494B1 (fr) Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
ZA958229B (en) Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor
NO910773L (no) Koboltbasert knalegering og anvendelse av denne.
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IT1230254B (it) Procedimento e dispositivo per la realizzazione di pannelli.
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
EP0796105A4 (fr) Compositions pharmaceutiques destinees au traitement de maladies auto-immunes et comprenant l'oligomere b de la toxine de pertussis ou ses sous-unites
FR2713266B3 (fr) Dispositif de fixation destiné à la fabrication de clôture ou autres.
FR2710845B1 (fr) Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
FR2695982B1 (fr) Dispositif lumineux destiné à la décoration intérieure et à l'habillement.
FR2713434B1 (fr) Billonneur-sillonneur destiné à la culture de l'igname.
PL310109A1 (en) Expression of protective antigens
NO960897D0 (no) Anordning for variasjon av egenskapene til veiv drevete mekanismer
FR2711307B1 (fr) Roulette pour meuble ou appareil destiné à la pratique d'un sport en salle.

Legal Events

Date Code Title Description
ST Notification of lapse